Skip to content
Dose Brief
Menu
No. 395 on the board · Grade C

Spry review

Spry is a weight-loss and anti-aging telehealth platform pairing compounded semaglutide ($199/mo) and tirzepatide ($299/mo) with three longevity peptides — BPC-157, NAD+, and sermorelin ($249–$299/mo).

Visit Spry Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $199/mo (starting dose, compounded)
Tirzepatide
From $299/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $199/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Spry scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability61/100
Transparency72/100
Access Breadth50/100
Clinical Oversight68/100
Track Record31/100

What we like

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

The caveats

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

The brief

Best for: Readers who want compounded GLP-1 plus anti-aging peptides under one membership. Spry is a weight-loss and anti-aging telehealth platform pairing compounded semaglutide ($199/mo) and tirzepatide ($299/mo) with three longevity peptides — BPC-157, NAD+, and sermorelin ($249–$299/mo).

Ranked #395 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest Spry — the realistic shortlist if you're weighing it.

Weighing Spry against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Spry, and every desk that outranks it is listed on the Spry alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Spry's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Spry's site. Not medical advice; see our disclosure.

← Back to all rankings